Comparison of deep learning‐based recurrence‐free survival with random survival forest and Cox proportional hazard models in Stage‐I NSCLC patients

Author:

Kar İrem1ORCID,Kocaman Gökhan2,İbrahimov Farrukh2,Enön Serkan2,Coşgun Erdal3,Elhan Atilla Halil1ORCID

Affiliation:

1. Department of Biostatistics Ankara University School of Medicine Ankara Turkey

2. Department of Thoracic Surgery Ankara University School of Medicine Ankara Turkey

3. Genomics Team, Microsoft Research & AI Redmond Washington USA

Abstract

AbstractBackgroundThe curative treatment for Stage I non‐small cell lung cancer (NSCLC) is surgical resection. Even for Stage I patients, the probability of recurrence after curative treatment is around 20%.MethodsIn this retrospective study, we included 268 operated Stage I NSCLC patients between January 2008 and June 2018 to analyze the prognostic factors (pathological stage, histological type, number of sampled mediastinal lymph node stations, type of resection, SUVmax of the lesion) that may affect relapse with three different methods, Cox proportional hazard (CoxPH), random survival forest (RSF), DeepSurv, and to compare the performance of these methods with Harrell's C‐index. The dataset was randomly split into two sets, training and test sets.ResultsIn the training set, DeepSurv showed the best performance among the three models, the C‐index of the training set was 0.832, followed by RSF (0.675) and CoxPH (0.672). In the test set, RSF showed the best performance among the three models, followed by DeepSurv with 0.677 and CoxPH methods with 0.625.ConclusionIn conclusion, machine‐learning techniques can be useful in predicting recurrence for lung cancer and guide clinicians both in choosing the adjuvant treatment options and best follow‐up programs.

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3